Riluzole: all 50 studies that test it
Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy ParticipantsNot yet recruitingNCT07618715Phase 1
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral SclerosisNot yet recruitingNCT07093268Phase 1
- Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy SubjectRecruitingNCT06935721Phase 1
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant SchizophreniaRecruitingNCT06270108Early Phase 1
- RiLuzole to Reduce Atrial FIb Study Using Holter MonitoringRecruitingNCT05292209Phase 2
- Riluzole in Patients With Spinocerebellar Ataxia Type 7RecruitingNCT03660917Phase 2/3
- Riluzole Orodispersible Film Replicate BioavailabilityCompletedNCT04819438Phase 1Results posted
- Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety DisorderCompletedNCT03017508Phase 2/3Results posted
- Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High InflammationCompletedNCT02796755Phase 4Results posted
- Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)CompletedNCT02155829Phase 1/2Results posted
- A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)CompletedNCT02019940Phase 1Results posted
- Riluzole in Mild Alzheimer's DiseaseCompletedNCT01703117Phase 2Results posted
- Riluzole Augmentation Pilot in Depression (RAPID) TrialTerminatedNCT01703039Phase 2Results posted
- Efficacy and Tolerability of Riluzole in Treatment Resistant DepressionCompletedNCT01204918Phase 2Results posted
- Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic NeurotransmissionCompletedNCT01018056Phase 4Results posted
- Riluzole in Fragile X SyndromeCompletedNCT00895752Phase 4Results posted
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00866840Phase 2Results posted
- Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar DisorderTerminatedNCT00805493Phase 2Results posted
- Riluzole in the Treatment of Bipolar DepressionCompletedNCT00544544Not applicableResults posted
- Riluzole Augmentation in Treatment-refractory Obsessive-compulsive DisorderCompletedNCT00523718Phase 2Results posted
- Neuroprotection With Riluzole Patients With Early Multiple SclerosisCompletedNCT00501943Phase 2Results posted
- A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar DepressionCompletedNCT00376220Phase 2Results posted
- Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2Results posted
- Riluzole to Treat Depression in Bipolar DisorderTerminatedNCT00054704Phase 2Results posted
- Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT04761614Phase 1
- Riluzole Effects on Hippocampus BiomarkersCompletedNCT04630444Early Phase 1
- Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.SuspendedNCT03722680Phase 2
- Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALSCompletedNCT03520517Phase 1
- Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)CompletedNCT03347344Phase 3
- Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury ConditionStatus unknownNCT02859792Phase 2
- Impact of Persistent Conductances on Motor Unit Firing in SCIStatus unknownNCT02136823Not applicable
- Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum DisordersCompletedNCT02081027Early Phase 1
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialCompletedNCT01910259Phase 2
- A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASDCompletedNCT01661855Phase 2
- Riluzole in Spinal Cord Injury StudyTerminatedNCT01597518Phase 2/3
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaActive, not recruitingNCT01303341Phase 1
- Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)CompletedNCT01257828Phase 3
- Efficacy of Riluzole in Hereditary Cerebellar AtaxiaCompletedNCT01104649Phase 2/3
- Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesTerminatedNCT01018836Phase 1
- Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast CancerWithdrawnNCT00903214Phase 1
- Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)CompletedNCT00774423Phase 2/3
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by SurgeryTerminatedNCT00667901Phase 1
- CARE Canadian ALS Riluzole EvaluationCompletedNCT00542412Phase 4
- Treatment of Refractory Schizophrenia With RiluzoleCompletedNCT00375050Not applicable
- Riluzole in Huntington's DiseaseCompletedNCT00277602Phase 3
- Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)TerminatedNCT00211224Phase 3
- Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar AtaxiaCompletedNCT00202397Phase 2
- Riluzole to Treat Major DepressionCompletedNCT00026052Phase 2